key: cord-0840246-ibjwq5bl authors: Biswas, Jyotirmay; Pradhan, Arkaprava title: Commentary: SARS-CoV-2 in tears: It really matters date: 2021-12-03 journal: Indian J Ophthalmol DOI: 10.4103/ijo.ijo_2391_21 sha: ab7d208aff3ddd01a1ba6b88f6a6f1296928cfb6 doc_id: 840246 cord_uid: ibjwq5bl nan Airborne respiratory droplet transmission is well recognized in coronavirus infection; however, ocular secretions, although being held responsible for the spread in many studies, have yet to be proven conclusively. [1, 2] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike proteins bind with the host cellular receptor, human angiotensin-converting enzyme 2, and gain entry into the cell in the presence of transmembrane serine protease 2, a cell surface-associated protease. [2] Angiotensin-converting enzyme 2 is known to be expressed on epithelial cells in the lungs, intestines, and kidneys. Recent reports indicate that both angiotensin-converting enzyme 2 and transmembrane serine protease 2 are present in human conjunctival and corneal cells, making the ocular surface cells a potential entry point and reservoir for transmission of the virus. [3] The shedding of viral RNA in tears has been observed in both the presence and the absence of ocular manifestations. [3] In this present study, authors have noted the RT-PCR positivity rate of 3.33% from conjunctival samples among 150 patients in their study. [1] Arora et al. [4] included 75 moderate to severe COVID-19-positive patients in their study and found a COVID-19 positivity rate of 24% from tear samples. Kaya et al. [5] also found a positivity rate of 16% from conjunctival samples. However, Seah et al. [2] could not detect viral RNA in any of the tear samples of 17 patients. One cross-sectional study by Zhang et al. [6] showed a 1% positivity rate. In the latter two studies, they collected the sample in the second and third week. But in the present study, the authors have followed the same procedure as Arora et al. [4] and collected the sample within 48 hours of collection of nasopharyngeal swab. In the study done by Arora et al., [4] tear samples were collected using conjunctival swabs and Schirmer paper strips. To obtain the conjunctival swab, the lower eyelid was retracted, the inferior fornix of the eye was swept with a sterile nylon swab for 10 seconds, and a similar procedure was repeated in the other eye. Güemes-Villahoz et al., [7] Azzolini et al., [8] and Kaya et al. [5] have also collected the sample by conjunctival swab. In this present study, the authors have collected the conjunctival swab sample as described above. The absence of ocular signs and symptoms in most of the patients with positive conjunctival swabs found in various studies implies that viral shedding in tears is not always related to ocular inflammation, as proposed previously. [7] The natural history of conjunctivitis in patients with COVID-19 seems to be self-limiting conjunctivitis that improves in a few days without specific treatment. There was no evidence of corneal infiltrates, membranes, or pseudomembranes. These characteristics differ from the conjunctivitis of other etiologies. [7] Study by Güemes-Villahoz et al. [7] showed that only 17% of the patients with conjunctivitis had severe disease and 33% had mild disease. The present study also showed no significant association between severity of the disease and conjunctival swab positivity, and no association was found between comorbidity and conjunctival swab positivity. [1] Seah et al. [2] evaluated the possibility of transmission through tears by assessing the presence of SARS-CoV-2 by viral isolation and RT-PCR analysis. A total of 64 samples were obtained during a 3-week period since the onset of symptoms. All samples showed negative results for SARS-CoV-2 on viral isolation and RT-PCR, suggesting that the risk of SARS-CoV-2 transmission through tears is low. Contrary to this, a case report from Italy collected ocular swabs almost daily from a 65-year-old woman with conjunctivitis, detecting SARS-CoV-2 RNA for 18 consecutive days (from days 3 to 21 of the disease), and then 5 days after it became undetectable, the virus was detected again in the ocular swab sample collected at day 27. These findings suggested sustained virus replication in the conjunctiva. [8] One important point is that the RT-PCR test does not possess 100% sensitivity; thus, a negative test may represent a false negative result and do not rule out the presence of SARS-CoV-2. To conclude, conjunctival swab is still a satisfactory method of tear collection for assessment of the presence of SARS-CoV-2 by RT-PCR analysis. Not only the respiratory tract but the precorneal tear film is also one of the transmission routes in patients with moderate to severe COVID-19. Thus, it implies that besides N95 masks, use of gloves, goggles, and face shields by healthcare workers should be mandatory when examining patients with COVID-19 to reduce the transmission of SARS-CoV-2. Clinical characteristics of Coronavirus disease 2019 in China Asymptomatic transmission, the achilles' heel of current strategies to control COVID-19 The trinity of COVID-19: Immunity, inflammation and intervention World Health Organization. Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations Droplets and aerosols in the transmission of SARS-CoV-2 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19 Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19 The evidence of SARS-CoV-2 infection on ocular surface Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19 Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease Assessment of Coronavirus in the conjunctival tears and secretions in patients with SARS-CoV-2 infection in Sohag Province Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients Evaluation of coronavirus in tears andconjunctival secretions of patients withSARS-CoV-2 infection Detection of SARS-CoV-2 RNA in a conjunctival swab sample in real-time-polymerase chain reaction positive COVID-19 patients and its association with comorbidity and severity at a designated COVID-19 hospital in Central India Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19 Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19 Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients The evidence of SARS-CoV-2 infection on ocular surface Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19 SARS-CoV-2 on ocular surfaces in a cohort of patients with COVID-19 from the Lombardy Region Commentary: SARS-CoV-2 in tears: It really matters This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Website: www.ijo.in 10.4103/ijo.IJO_2391_21 *****